Variant report

Variant	nsv827031
Chromosome Location	chr1:228344082-228349790
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:75)
CpG islands
(count:488)
Chromatin interactive
region (count:6)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:75 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BHLHE40	chr1:228343974-228344190	K562	blood:	n/a	n/a
2	CEBPB	chr1:228349274-228349353	Hela-S3	cervix:	n/a	n/a
3	CHD2	chr1:228349141-228349341	Hela-S3	cervix:	n/a	n/a
4	CTCF	chr1:228349200-228349350	HEEpiC	esophagus:	n/a	n/a
5	FOS	chr1:228349124-228349267	MCF10A-Er-Src	breast:	n/a	n/a
6	FOXA2	chr1:228348139-228348342	HepG2	liver:	n/a	n/a
7	GABPA	chr1:228345806-228346237	H1-hESC	embryonic stem cell:	n/a	n/a
8	MAFK	chr1:228348138-228348326	HepG2	liver:	n/a	n/a
9	MAFK	chr1:228348242-228348289	HepG2	liver:	n/a	n/a
10	MAX	chr1:228343914-228344216	K562	blood:	n/a	chr1:228344067-228344077
11	MAX	chr1:228345992-228346367	H1-hESC	embryonic stem cell:	n/a	n/a
12	MAX	chr1:228343946-228344203	H1-hESC	embryonic stem cell:	n/a	chr1:228344067-228344077
13	MAX	chr1:228347577-228347643	NB4	blood:	n/a	chr1:228347579-228347589
14	MAX	chr1:228344153-228344159	A549	lung:	n/a	n/a
15	MAX	chr1:228343778-228344309	HUVEC	blood vessel:	n/a	chr1:228344067-228344077
16	MAX	chr1:228343879-228344237	NB4	blood:	n/a	chr1:228344067-228344077
17	MYC	chr1:228349039-228349098	MCF10A-Er-Src	breast:	n/a	n/a
18	POLR2A	chr1:228349182-228354536	Hela-S3	cervix:	n/a	n/a
19	POLR2A	chr1:228349701-228350036	GM12878	blood:	n/a	n/a
20	POLR2A	chr1:228349224-228349225	MCF-7	breast:	n/a	n/a
21	POLR2A	chr1:228348937-228354538	MCF10A-Er-Src	breast:	n/a	n/a
22	POLR2A	chr1:228348101-228348126	HepG2	liver:	n/a	n/a
23	POLR2A	chr1:228349261-228349353	K562	blood:	n/a	n/a
24	POLR2A	chr1:228347421-228347435	HepG2	liver:	n/a	n/a
25	POLR2A	chr1:228348375-228348749	Hela-S3	cervix:	n/a	n/a
26	POLR2A	chr1:228349193-228349194	K562	blood:	n/a	n/a
27	POLR2A	chr1:228343934-228344118	Gliobla	brain:	n/a	n/a
28	POLR2A	chr1:228349143-228349364	Hela-S3	cervix:	n/a	n/a
29	POLR2A	chr1:228344596-228344622	HUVEC	blood vessel:	n/a	n/a
30	POLR2A	chr1:228348004-228348073	HepG2	liver:	n/a	n/a
31	POLR2A	chr1:228348458-228348490	Hela-S3	cervix:	n/a	n/a
32	POLR2A	chr1:228349242-228349253	Gliobla	brain:	n/a	n/a
33	POLR2A	chr1:228348465-228348545	MCF10A-Er-Src	breast:	n/a	n/a
34	POLR2A	chr1:228349546-228349550	Hela-S3	cervix:	n/a	n/a
35	POLR2A	chr1:228349082-228351793	Hela-S3	cervix:	n/a	n/a
36	POLR2A	chr1:228344050-228344351	HUVEC	blood vessel:	n/a	n/a
37	POLR2A	chr1:228348184-228348325	Hela-S3	cervix:	n/a	n/a
38	POLR2A	chr1:228346592-228346657	K562	blood:	n/a	n/a
39	POLR2A	chr1:228349743-228349807	Gliobla	brain:	n/a	n/a
40	POLR2A	chr1:228343977-228344145	GM12878	blood:	n/a	n/a
41	POLR2A	chr1:228348492-228348585	MCF10A-Er-Src	breast:	n/a	n/a
42	POLR2A	chr1:228346061-228346151	HUVEC	blood vessel:	n/a	n/a
43	POLR2A	chr1:228349787-228349797	MCF-7	breast:	n/a	n/a
44	POLR2A	chr1:228349117-228349868	HepG2	liver:	n/a	n/a
45	POLR2A	chr1:228348493-228348818	HepG2	liver:	n/a	n/a
46	POLR2A	chr1:228349077-228349422	Hela-S3	cervix:	n/a	n/a
47	POLR2A	chr1:228349204-228352644	Raji	blood:	n/a	n/a
48	POLR2A	chr1:228347446-228347659	HepG2	liver:	n/a	n/a
49	POLR2A	chr1:228349254-228349288	Gliobla	brain:	n/a	n/a
50	POLR2A	chr1:228348821-228349486	MCF10A-Er-Src	breast:	n/a	n/a

(count:488 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr1:228345490-228345540	SK-N-SH	brain:	n/a
2	chr1:228347181-228347231	MCF-7	breast:	n/a
3	chr1:228347181-228347231	SK-N-SH_RA	brain:	n/a
4	chr1:228345378-228345428	IMR90	lung:	fetal
5	chr1:228345324-228345374	IMR90	lung:	fetal
6	chr1:228347181-228347231	GM12892	blood:	n/a
7	chr1:228345490-228345540	K562	blood:	n/a
8	chr1:228346181-228346231	RPTEC	kidney:	n/a
9	chr1:228346338-228346388	HIPEpiC	eye:	n/a
10	chr1:228345324-228345374	NH-A	brain:	n/a
11	chr1:228345324-228345374	HPAEpiC	pulmonary alveolar:	n/a
12	chr1:228345378-228345428	Caco-2	colon:	n/a
13	chr1:228345324-228345374	AoSMC	blood vessel:	n/a
14	chr1:228346181-228346231	HepG2	liver:	n/a
15	chr1:228346014-228346064	U87	brain:	n/a
16	chr1:228346347-228346397	LNCaP	prostate:	n/a
17	chr1:228346338-228346388	HRE	kidney:	n/a
18	chr1:228345490-228345540	NHBE	bronchial:	n/a
19	chr1:228346181-228346231	T-47D	breast:	n/a
20	chr1:228347181-228347231	AG09309	skin:	n/a
21	chr1:228346338-228346388	SKMC	muscle:	n/a
22	chr1:228347181-228347231	ovcar-3	ovarian:	n/a
23	chr1:228346014-228346064	AG10803	skin:	n/a
24	chr1:228346347-228346397	SK-N-MC	brain:	n/a
25	chr1:228345378-228345428	AoSMC	blood vessel:	n/a
26	chr1:228346347-228346397	NH-A	brain:	n/a
27	chr1:228346338-228346388	NHDF-neo	bronchial:	n/a
28	chr1:228345324-228345374	HRPEpiC	eye:	n/a
29	chr1:228346014-228346064	RPTEC	kidney:	n/a
30	chr1:228346347-228346397	SAEC	small airway:	n/a
31	chr1:228347181-228347231	SAEC	small airway:	n/a
32	chr1:228346014-228346064	AG09319	gingival:	n/a
33	chr1:228345324-228345374	LNCaP	prostate:	n/a
34	chr1:228346181-228346231	SK-N-MC	brain:	n/a
35	chr1:228345324-228345374	NT2-D1	testis:	n/a
36	chr1:228346338-228346388	HAEpiC	amniotic membrane:	n/a
37	chr1:228346347-228346397	Jurkat	blood:	n/a
38	chr1:228346014-228346064	HEK293	kidney:	embryo
39	chr1:228346014-228346064	GM12878	blood:	n/a
40	chr1:228345378-228345428	U87	brain:	n/a
41	chr1:228345378-228345428	GM12891	blood:	n/a
42	chr1:228345490-228345540	HMEC	breast:	n/a
43	chr1:228346181-228346231	HCM	heart:	n/a
44	chr1:228346347-228346397	NT2-D1	testis:	n/a
45	chr1:228346181-228346231	IMR90	lung:	fetal
46	chr1:228346181-228346231	SK-N-SH	brain:	n/a
47	chr1:228345378-228345428	NHBE	bronchial:	n/a
48	chr1:228347181-228347231	Jurkat	blood:	n/a
49	chr1:228345324-228345374	SK-N-MC	brain:	n/a
50	chr1:228346347-228346397	BE2_C	brain:	n/a

(count:6 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr1:228282033..228284613-chr1:228342310..228344410,2	MCF-7	breast:
2	chr1:228349528..228352253-chr1:228378425..228381248,2	MCF-7	breast:
3	chr1:228349005..228351267-chr1:228399085..228402017,2	MCF-7	breast:
4	chr1:228347944..228349967-chr1:228460041..228462528,2	K562	blood:
5	chr1:228343198..228344704-chr1:228404539..228407474,2	MCF-7	breast:
6	chr1:228314188..228315980-chr1:228346492..228348438,2	K562	blood:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-GJC2-1	chr1:228348810-228349358	NONHSAT009993

No data

Variant related genes	Relation type
IBA57	TF binding region
IBA57	CpG island
ENSG00000162913	chromatin interactions
ENSG00000269890	chromatin interactions

Extended variants
information (count: 212 )
Associated
traits (count: 93 )

Variant overlapped rSNPs/rCNVs (count:212 , 50 per page) page: 1 2 3 4 5

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs553925791	chr1:228344091-228344092	Flanking Active TSS Genic enhancers Weak transcription Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
2	rs573830974	chr1:228344109-228344110	Flanking Active TSS Genic enhancers Weak transcription Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
3	rs542851424	chr1:228344114-228344115	Flanking Active TSS Genic enhancers Weak transcription Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
4	rs556436743	chr1:228344147-228344148	Flanking Active TSS Genic enhancers Weak transcription Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
5	rs534601725	chr1:228344150-228344151	Flanking Active TSS Genic enhancers Weak transcription Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
6	rs368102157	chr1:228344226-228344227	Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs182102752	chr1:228344280-228344281	Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs547813013	chr1:228344281-228344282	Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs545001530	chr1:228344313-228344314	Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs565250528	chr1:228344332-228344333	Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs527707762	chr1:228344347-228344348	Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs76896964	chr1:228344378-228344379	Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs187982784	chr1:228344398-228344399	Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs530177045	chr1:228344507-228344508	Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs111905275	chr1:228344568-228344569	Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs570183694	chr1:228344569-228344570	Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs532826961	chr1:228344614-228344615	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs552609048	chr1:228344641-228344642	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs571193071	chr1:228344655-228344656	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs183815346	chr1:228344660-228344661	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs576612421	chr1:228344693-228344694	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs567359235	chr1:228344739-228344740	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs574035639	chr1:228344819-228344820	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
24	rs536398285	chr1:228344831-228344832	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
25	rs539180577	chr1:228344834-228344835	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
26	rs556371473	chr1:228344865-228344866	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
27	rs111427073	chr1:228344880-228344881	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
28	rs576191602	chr1:228344882-228344883	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
29	rs188779706	chr1:228344966-228344967	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
30	rs151119099	chr1:228344969-228344970	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
31	rs572366103	chr1:228344977-228344978	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
32	rs541018245	chr1:228345010-228345011	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs141093786	chr1:228345013-228345014	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs574572877	chr1:228345028-228345029	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs140606139	chr1:228345065-228345066	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs201230346	chr1:228345149-228345150	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs543546801	chr1:228345198-228345199	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs559463555	chr1:228345216-228345217	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs563873751	chr1:228345238-228345239	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs149837848	chr1:228345248-228345249	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs552786140	chr1:228345285-228345286	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs559803779	chr1:228345303-228345304	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs528832817	chr1:228345325-228345326	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs547412690	chr1:228345334-228345335	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs376318575	chr1:228345351-228345352	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs567296544	chr1:228345370-228345371	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs536337713	chr1:228345378-228345379	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs549625102	chr1:228345392-228345393	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs569785905	chr1:228345393-228345394	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs577811454	chr1:228345402-228345403	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:93)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
HIV/AIDS	22032296	CNVD
Schizophrenia	19415332	CNVD
Autism	22495311	CNVD
Melanoma	18172304	CNVD
Rett syndrome	21593744	CNVD
Medulloblastoma	21979893	CNVD
Cancer	20164919	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	17133270	CNVD
Non-small cell lung cancer	21044232	CNVD
Cervical cancer	21063398	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	20632083	CNVD
Endometrial cancer	22040021	CNVD
Ewing''s sarcoma	21437220	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	21080181	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	21264507	CNVD
Liposarcoma	21253554	CNVD
Multiple myeloma	21628407	CNVD
Cancer	16751803	CNVD
Prostate cancer	16705090	CNVD
Neuroblastoma	19435921	CNVD
Breast cancer	17850661	CNVD
Breast cancer	16461572	CNVD
Intracranial tumor	16823260	CNVD
Medulloblastoma	18056178	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Colorectal cancer	16272173	CNVD
Breast cancer	17603634	CNVD
Neuroblastoma	21899760	CNVD
Breast cancer	21858162	CNVD
Non-small cell lung cancer	21385341	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	16608533	CNVD
Ewing''s sarcoma	22429812	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17001317	CNVD
Acute myeloid leukemia	21251322	CNVD
Multiple myeloma	17550852	CNVD
Prostate cancer	18632612	CNVD
Acute myeloid leukemia	20729466	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Testicular germ cell tumor	18059402	CNVD
Ependymoma	18628472	CNVD
Leukemia	18628472	CNVD
Neuroblastoma	18923191	CNVD
Acute lymphoblastic leukemia	19100363	CNVD
Breast cancer	21509527	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Urothelial carcinoma	21177765	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Chordoma	18071362	CNVD
T-cell lymphomas	19863542	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hepatocellular carcinoma	18803288	CNVD
Urothelial tumor	18831757	CNVD
Lung cancer	18438408	CNVD
Medulloblastoma	16783165	CNVD
Basal cell lymphoma	17170743	CNVD
Mental retardation	19951919	CNVD
Non-syndromic sensorineural hearing loss	17873649	CNVD
Basal cell lymphoma	17053054	CNVD
Autism	14699429	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Fumarase deficiency	21572526	CNVD
Autism	17483303	CNVD
Kartagener syndrome	16639409	CNVD
Congenital abnormalities	21549014	CNVD
Developmental delay	21549014	CNVD
Mental retardation	21549014	CNVD
small cell lung cancer	20016488	CNVD
Glioblastoma multiforme	21138945	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Cancer	20164920	CNVD
Cancer	17060936	CNVD
Myelofibrosis	22110671	CNVD
abnormal development	18461090	CNVD
Breast cancer	21364760	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Lung adenocarcinoma	21935476	CNVD
early-passage human iPS cells	21368824	CNVD

Chromatin state (count:296 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr1:228332800-228349800	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
2	chr1:228333200-228344600	Weak transcription	Primary T helper naive cells from peripheral blood	blood
3	chr1:228333800-228350400	Weak transcription	Primary B cells from cord blood	blood
4	chr1:228336800-228350200	Weak transcription	Sigmoid Colon	Sigmoid Colon
5	chr1:228337200-228344400	Weak transcription	Primary B cells from peripheral blood	blood
6	chr1:228337800-228349800	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
7	chr1:228338000-228349200	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
8	chr1:228338000-228349600	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
9	chr1:228338200-228344800	Weak transcription	Primary T regulatory cells fromperipheralblood	blood
10	chr1:228338200-228344800	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
11	chr1:228338200-228352400	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
12	chr1:228338400-228349200	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
13	chr1:228339000-228346000	Weak transcription	HMEC	breast
14	chr1:228339400-228344400	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
15	chr1:228339400-228344400	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
16	chr1:228339400-228345000	Weak transcription	Breast Myoepithelial Primary Cells	Breast
17	chr1:228339400-228352600	Weak transcription	Brain Anterior Caudate	brain
18	chr1:228339600-228345600	Weak transcription	Right Atrium	heart
19	chr1:228339600-228349000	Weak transcription	NHLF	lung
20	chr1:228339800-228349400	Weak transcription	Brain Angular Gyrus	brain
21	chr1:228340000-228349200	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
22	chr1:228340200-228345200	Weak transcription	Right Ventricle	heart
23	chr1:228340600-228349600	Weak transcription	Colon Smooth Muscle	Colon
24	chr1:228341000-228344200	Enhancers	Fetal Thymus	thymus
25	chr1:228341600-228344400	Enhancers	Thymus	Thymus
26	chr1:228341800-228345400	Enhancers	Primary T helper cells PMA-I stimulated	--
27	chr1:228342000-228344200	Enhancers	Primary T cells from cord blood	blood
28	chr1:228342000-228344200	Enhancers	Primary T killer naive cells fromperipheralblood	blood
29	chr1:228342000-228344400	Enhancers	Primary T cells fromperipheralblood	blood
30	chr1:228342200-228345200	Enhancers	Primary T helper naive cells fromperipheralblood	blood
31	chr1:228342600-228344200	Genic enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
32	chr1:228342600-228344200	Enhancers	Esophagus	oesophagus
33	chr1:228342600-228344200	Enhancers	Hela-S3	cervix
34	chr1:228342600-228350000	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
35	chr1:228342800-228344400	Bivalent Enhancer	Fetal Muscle Leg	muscle
36	chr1:228342800-228345800	Enhancers	Lung	lung
37	chr1:228342800-228346400	Weak transcription	Stomach Smooth Muscle	stomach
38	chr1:228343000-228344200	Enhancers	Fetal Heart	heart
39	chr1:228343000-228347200	Weak transcription	Brain Cingulate Gyrus	brain
40	chr1:228343200-228345600	Weak transcription	Placenta Amnion	Placenta Amnion
41	chr1:228343200-228349200	Weak transcription	K562	blood
42	chr1:228343400-228344200	Enhancers	Brain Inferior Temporal Lobe	brain
43	chr1:228343400-228344800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
44	chr1:228343400-228344800	Weak transcription	Fetal Intestine Small	intestine
45	chr1:228343400-228347400	Weak transcription	NHEK	skin
46	chr1:228343400-228352400	Weak transcription	A549	lung
47	chr1:228343600-228344200	Genic enhancers	Spleen	Spleen
48	chr1:228343800-228344200	Genic enhancers	Brain Substantia Nigra	brain
49	chr1:228343800-228344200	Enhancers	Gastric	stomach
50	chr1:228343800-228344200	Enhancers	Pancreas	Pancrea

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links